China has long been plagued with high corruption risk. However, the recent uptick in China’s own anti-corruption enforcement – evidenced recently by the fine the Chinese government levied on GSK – is changing the corruption landscape there, as is the steady focus on China by U.S. regulators. In this installment of the Anti-Corruption Report’s Regional Risk Spotlight series, we talk to William McGovern, a partner in Kobre & Kim’s Hong Kong office, about the most pressing corruption issues in China and how companies doing business there can handle them. See also “Understanding and Tackling China’s Corruption Challenges” (Mar. 5, 2014).
-
- |
